WIN-Partners Co., Ltd.
Research WIN-Partners Co., Ltd. (3183.T) on Bullrun: market cap JPY 34.37B, P/E 17.3, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3183.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyJPY
- Market capJPY 34.37B
- P/E17.3
- Dividend yield4.4%
- Financial periodFY2026
- RevenueJPY 90.39B
- Revenue growth11.0%
- Net incomeJPY 2.12B
- Free cash flowJPY 2.70B
- Gross margin11.8%
Valuation Snapshot
latest market cap is JPY 34.37B; P/E is 17.3; dividend yield is 4.4%.
Peer valuation comparison
Latest P/E is 17.25x versus a Healthcare sector median of 21.69x (20.5% below).
Latest dividend yield is 4.35% versus a Healthcare sector median of 2.41% (80.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 90.39B | JPY 2.12B | JPY 2.70B | 11.8% | 75.98 | JPY 15.93B | JPY 713.06M | JPY 23.29B |
| FY2025 | JPY 81.41B | JPY 2.02B | JPY 1.59B | 12.2% | 70.62 | JPY 16.21B | JPY 0 | JPY 24.07B |
| FY2024 | JPY 77.06B | JPY 1.84B | JPY 2.54B | 12.4% | 64.4 | JPY 18.16B | n/a | JPY 23.39B |
| FY2023 | JPY 70.85B | JPY 2.05B | -JPY 525.17M | 12.2% | 72.04 | JPY 16.77B | n/a | JPY 22.78B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 34.37B | 17.3 | 4.4% | 55 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 55 JPY, yield 4.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 54 JPY |
| FY2025 | 52 JPY |
| FY2024 | 50 JPY |
| FY2023 | 50 JPY |
| FY2022 | 35 JPY |
About WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., through its subsidiaries, engages in the sales of medical equipment in Japan. The company offers PTCA balloon catheters and intravascular ultrasound diagnostic catheters for Ischemic heart disease-related; cardiac rhythm management, includes space makers, implantable cardioverter-defibrillators, implantable cardioverter-defibrillators with biventricular pacing, catheters for electrophysiological testing, and catheters for myocardial ablation;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is WIN-Partners Co., Ltd.'s market cap?
WIN-Partners Co., Ltd.'s market capitalization is JPY 34.37B.
What is WIN-Partners Co., Ltd.'s P/E ratio?
WIN-Partners Co., Ltd.'s price-to-earnings (P/E) ratio is 17.3.
Does WIN-Partners Co., Ltd. pay a dividend?
WIN-Partners Co., Ltd. has a dividend yield of 4.4%.
What does WIN-Partners Co., Ltd. do?
WIN-Partners Co., Ltd., through its subsidiaries, engages in the sales of medical equipment in Japan. The company offers PTCA balloon catheters and intravascular ultrasound diagnostic catheters for Ischemic heart disease-related; cardiac rhythm management, includes space makers, implantable cardioverter-defibrillators, implantable cardioverter-defibrillators with biventricular pacing, catheters for electrophysiological testing, and catheters for myocardial ablation; and stent grafts, transcatheter bioprosthetic valves, artificial blood vessels, heart-lung machines for cardiovascular surgery.